Literature DB >> 33346713

CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates.

Eirik A Moreb1, Mitchell Hutmacher1, Michael D Lynch1.   

Abstract

CRISPR-Cas systems have become ubiquitous for genome editing in eukaryotic as well as bacterial systems. Cas9 forms a complex with a guide RNA (gRNA) and searches DNA for a matching sequence (target site) next to a protospacer adjacent motif (PAM). Once found, Cas9 cuts the DNA. Cas9 is revolutionary for the ability to change the RNA sequence and target a new site easily. However, while algorithms have been developed to predict gRNA-specific Cas9 activity, a fundamental biological understanding of gRNA-specific activity is lacking. The number of PAM sites in the genome is effectively a large pool of inhibitory substrates, competing with the target site for the Cas9/gRNA complex. We demonstrate that increasing the number of non-target sites for a given gRNA reduces on-target activity in a dose-dependent manner. Furthermore, we show that the use of Cas9 mutants with increased PAM specificity toward a smaller subset of PAMs (or smaller pool of competitive substrates) improves cutting rates, while increased PAM promiscuity decreases cutting rates. Decreasing the potential search space by increasing PAM specificity provides a path toward improving on-target activity for slower high-fidelity Cas9 variants. Engineering improved PAM specificity to reduce the competitive search space offers an alternative strategy to engineer Cas9 variants with increased specificity and maintained on-target activity.

Year:  2020        PMID: 33346713     DOI: 10.1089/crispr.2020.0065

Source DB:  PubMed          Journal:  CRISPR J        ISSN: 2573-1599


  4 in total

1.  Precise DNA cleavage using CRISPR-SpRYgests.

Authors:  Kathleen A Christie; Jimmy A Guo; Rachel A Silverstein; Roman M Doll; Megumu Mabuchi; Hannah E Stutzman; Jiecong Lin; Linyuan Ma; Russell T Walton; Luca Pinello; G Brett Robb; Benjamin P Kleinstiver
Journal:  Nat Biotechnol       Date:  2022-10-06       Impact factor: 68.164

2.  Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes.

Authors:  Jeremy Vicencio; Carlos Sánchez-Bolaños; Ismael Moreno-Sánchez; David Brena; Charles E Vejnar; Dmytro Kukhtar; Miguel Ruiz-López; Mariona Cots-Ponjoan; Alejandro Rubio; Natalia Rodrigo Melero; Jesús Crespo-Cuadrado; Carlo Carolis; Antonio J Pérez-Pulido; Antonio J Giráldez; Benjamin P Kleinstiver; Julián Cerón; Miguel A Moreno-Mateos
Journal:  Nat Commun       Date:  2022-05-12       Impact factor: 17.694

3.  An Alternate Approach to Generate Induced Pluripotent Stem Cells with Precise CRISPR/Cas9 Tool.

Authors:  Nasir Javaid; Sangdun Choi
Journal:  Stem Cells Int       Date:  2022-09-22       Impact factor: 5.131

4.  AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines.

Authors:  Liyang Zhang; John A Zuris; Ramya Viswanathan; Jasmine N Edelstein; Rolf Turk; Bernice Thommandru; H Tomas Rube; Steve E Glenn; Michael A Collingwood; Nicole M Bode; Sarah F Beaudoin; Swarali Lele; Sean N Scott; Kevin M Wasko; Steven Sexton; Christopher M Borges; Mollie S Schubert; Gavin L Kurgan; Matthew S McNeill; Cecilia A Fernandez; Vic E Myer; Richard A Morgan; Mark A Behlke; Christopher A Vakulskas
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.